Troxyca® ER (oxycodone/naltrexone) – New drug approval
August 19, 2016 – Pfizer announced the FDA approval of Troxyca ER (oxycodone/naltrexone) for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Top